99 related articles for article (PubMed ID: 29957974)
1. Complete Response of Metastatic Melanoma to Second Line Chemotherapy with Paclitaxel and Carboplatin - Case Report.
Tomić K; Tica Sedlar I; Berić Jozić G; Marijanović I; Lukić B; Miletić D; Puljić Ćuk A
Acta Med Acad; 2018 May; 47(1):82-87. PubMed ID: 29957974
[TBL] [Abstract][Full Text] [Related]
2. Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma.
Rao RD; Holtan SG; Ingle JN; Croghan GA; Kottschade LA; Creagan ET; Kaur JS; Pitot HC; Markovic SN
Cancer; 2006 Jan; 106(2):375-82. PubMed ID: 16342250
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of nab-paclitaxel combined with carboplatin in Chinese patients with melanoma.
Guo YQ; Ding Y; Li DD; Li JJ; Peng RQ; Wen XZ; Zhang X; Zhang XS
Med Oncol; 2015 Sep; 32(9):234. PubMed ID: 26298530
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanoma.
Pflugfelder A; Eigentler TK; Keim U; Weide B; Leiter U; Ikenberg K; Berneburg M; Garbe C
PLoS One; 2011 Feb; 6(2):e16882. PubMed ID: 21359173
[TBL] [Abstract][Full Text] [Related]
5. Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine.
Lee CK; Jung M; Choi HJ; Kim HR; Kim HS; Roh MR; Ahn JB; Chung HC; Heo SJ; Rha SY; Shin SJ
Cancer Res Treat; 2015 Oct; 47(4):781-9. PubMed ID: 25687848
[TBL] [Abstract][Full Text] [Related]
6. Effect of paclitaxel/carboplatin salvage chemotherapy in noncutaneous versus cutaneous metastatic melanoma.
Chang W; Lee SJ; Park S; Choi MK; Hong JY; Kim YS; Maeng CH; Jung HA; Kim S; Lee J
Melanoma Res; 2013 Apr; 23(2):147-51. PubMed ID: 23411477
[TBL] [Abstract][Full Text] [Related]
7. Response to paclitaxel and carboplatin in metastatic salivary gland cancer: a case report.
Ruzich JC; Ciesla MC; Clark JI
Head Neck; 2002 Apr; 24(4):406-10. PubMed ID: 11933184
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy of carboplatin and paclitaxel for metastatic melanoma.
Sato Y; Uhara H; Ashida A; Okuyama R
J Dermatol; 2013 Dec; 40(12):1050-1. PubMed ID: 24330169
[No Abstract] [Full Text] [Related]
9. Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma.
Hauschild A; Agarwala SS; Trefzer U; Hogg D; Robert C; Hersey P; Eggermont A; Grabbe S; Gonzalez R; Gille J; Peschel C; Schadendorf D; Garbe C; O'Day S; Daud A; White JM; Xia C; Patel K; Kirkwood JM; Keilholz U
J Clin Oncol; 2009 Jun; 27(17):2823-30. PubMed ID: 19349552
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy of carboplatin and paclitaxel for advanced/metastatic salivary gland carcinoma patients: differences in responses by different pathological diagnoses.
Nakano K; Sato Y; Sasaki T; Shimbashi W; Fukushima H; Yonekawa H; Mitani H; Kawabata K; Takahashi S
Acta Otolaryngol; 2016 Sep; 136(9):948-51. PubMed ID: 27094013
[TBL] [Abstract][Full Text] [Related]
11. Clinical Benefit of Sorafenib Combined with Paclitaxel and Carboplatin to a Patient with Metastatic Chemotherapy-Refractory Testicular Tumors.
Lian B; Zhang W; Wang T; Yang Q; Jia Z; Chen H; Wang L; Xu J; Wang W; Cao K; Gao X; Sun Y; Shao C; Liu Z; Li J
Oncologist; 2019 Dec; 24(12):e1437-e1442. PubMed ID: 31492770
[TBL] [Abstract][Full Text] [Related]
12. Case of pure ovarian squamous cell carcinoma resistant to combination chemotherapy with paclitaxel and carboplatin but responsive to monotherapy with weekly irinotecan.
Nakamura Y; Kamei T; Shinagawa M; Sakamoto Y; Miwa I
J Obstet Gynaecol Res; 2015 May; 41(5):809-12. PubMed ID: 25511544
[TBL] [Abstract][Full Text] [Related]
13. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D
Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237
[TBL] [Abstract][Full Text] [Related]
14. Treatment of metastatic melanoma with pazopanib: A report of five patient cases.
Dayer LE; Hutchins LF; Johnson JT
J Oncol Pharm Pract; 2015 Jun; 21(3):224-31. PubMed ID: 24576945
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel Carboplatin chemotherapy as a second-line chemotherapy for advanced platinum resistant urothelial cancer in Japanese cases.
Soga N; Onishi T; Arima K; Sugimura Y
Int J Urol; 2007 Sep; 14(9):828-32. PubMed ID: 17760750
[TBL] [Abstract][Full Text] [Related]
16. Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial.
Zhang P; Yin Y; Mo H; Zhang B; Wang X; Li Q; Yuan P; Wang J; Zheng S; Cai R; Ma F; Fan Y; Xu B
Oncotarget; 2016 Sep; 7(37):60647-60656. PubMed ID: 27447966
[TBL] [Abstract][Full Text] [Related]
17. [A case of metastatic choriocarcinoma responding to combination chemotherapy with paclitaxel and carboplatin].
Shimamoto K; Inatomi S; Fujimoto H; Sumioki H
Gan To Kagaku Ryoho; 2010 May; 37(5):943-6. PubMed ID: 20495335
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel and carboplatin combination chemotherapy for recurrent endometrial cancer.
Obata H; Aoki Y; Watanabe M; Matsushita H; Yahata T; Fujita K; Kurata H; Tanaka K
Int J Clin Oncol; 2003 Feb; 8(1):53-5. PubMed ID: 12601544
[TBL] [Abstract][Full Text] [Related]
19. Everolimus in combination with paclitaxel and carboplatin in patients with metastatic melanoma: a phase II trial of the Sarah Cannon Research Institute Oncology Research Consortium.
Hauke RJ; Infante JR; Rubin MS; Shih KC; Arrowsmith ER; Hainsworth JD
Melanoma Res; 2013 Dec; 23(6):468-73. PubMed ID: 23969699
[TBL] [Abstract][Full Text] [Related]
20. The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias.
Fujita T; Hiroishi T; Shikano K; Yanagisawa A; Hayama N; Amano H; Nakamura M; Hirano S; Tabeta H; Nakamura S
Intern Med; 2018 Jul; 57(13):1827-1832. PubMed ID: 29434143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
